Factors associated with tracheostomy-associated infection treatment: A multicenter observational study
- PMID: 38860585
- DOI: 10.1002/ppul.27117
Factors associated with tracheostomy-associated infection treatment: A multicenter observational study
Abstract
Objective: To characterize factors that influence the decision to treat suspected pediatric bacterial tracheostomy-associated respiratory infections (bTRAINs; e.g., pneumonia, tracheitis).
Methods: We conducted a multicenter, prospective cohort study of children with pre-existing tracheostomy hospitalized at six children's hospitals for a suspected bTRAIN (receipt of respiratory culture plus ≥1 doses of an antibiotic within 48 h). The primary predictor was respiratory culture growth categorized as Pseudomonas aeruginosa, P. aeruginosa + ≥1 other bacterium, other bacteria alone, or normal flora/no growth. Our primary outcome was bTRAIN treatment with a complete course of antibiotics as documented by the discharge team. We used logistic regression with generalized estimating equations to identify the association between our primary predictor and outcome and to identify demographic, clinical, and diagnostic testing factors associated with treatment.
Results: Of the 440 admissions among 289 patients meeting inclusion criteria, 307 (69.8%) had positive respiratory culture growth. Overall, 237 (53.9%) of admissions resulted in bTRAIN treatment. Relative to a negative culture, a culture positive for P. aeruginosa plus ≥1 other organism (adjusted odds ratio [aOR] 2.3; 95% confidence interval [CI] 1.02-5.0)] or ≥1 other organism alone (aOR: 2.8; 95% CI: 1.4-5.6)] was associated with treatment. Several clinical and diagnostic testing (respiratory Gram-stain and chest radiograph) findings were also associated with treatment. Positive respiratory viral testing was associated with reduced odds of treatment (aOR: 0.5; 95% CI: 0.2-0.9).
Conclusions: Positive respiratory cultures as well as clinical indicators of acute illness and nonculture test results were associated with bTRAIN treatment. Clinicians may be more comfortable withholding antibiotics when a virus is identified during testing.
Keywords: Pseudomonas aeruginosa; pediatrics; pneumonia; tracheitis; tracheostomy.
© 2024 Wiley Periodicals LLC.
Similar articles
-
Development of Chronic Pseudomonas aeruginosa-Positive Respiratory Cultures in Children with Tracheostomy.Lung. 2019 Dec;197(6):811-817. doi: 10.1007/s00408-019-00285-6. Epub 2019 Oct 31. Lung. 2019. PMID: 31673781 Free PMC article.
-
Pseudomonas aeruginosa and post-tracheotomy bacterial respiratory tract infection readmissions.Pediatr Pulmonol. 2017 Sep;52(9):1212-1218. doi: 10.1002/ppul.23716. Epub 2017 Apr 25. Pediatr Pulmonol. 2017. PMID: 28440922 Free PMC article.
-
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.Clin Ther. 2009 Feb;31(2):299-310. doi: 10.1016/j.clinthera.2009.02.015. Clin Ther. 2009. PMID: 19302902 Clinical Trial.
-
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.Cochrane Database Syst Rev. 2023 Jun 2;6(6):CD004197. doi: 10.1002/14651858.CD004197.pub6. Cochrane Database Syst Rev. 2023. PMID: 37268599 Free PMC article. Review.
-
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD004197. doi: 10.1002/14651858.CD004197.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2023 Jun 2;6:CD004197. doi: 10.1002/14651858.CD004197.pub6. PMID: 28440853 Free PMC article. Updated. Review.
References
REFERENCES
-
- Akangire G, Manimtim W, Nyp M, et al. Factors leading to rehospitalization for tracheostomized and ventilator‐dependent infants through 2 years of age. J Perinatol. 2017;37(7):857‐863. doi:10.1038/jp.2017.54
-
- Chew L, Su‐Velez BM, Miller JE, West AN. 30‐Day readmission rates, diagnoses, and risk factors following pediatric airway surgery. Int J Pediatr Otorhinolaryngol. 2020;136(March):110141. doi:10.1016/j.ijporl.2020.110141
-
- Ertugrul A, Baykacı B, Ertugrul I, Kesici S, Gunes Yalcin E. Clinical evaluation of invasive home mechanical ventilation dependent pediatric patients. Iran J Ped. 2017;27(4):ARTN e9531. doi:10.5812/ijp.9531
-
- Kun SS, Edwards JD, Davidson Ward SL, Keens TG. Hospital readmissions for newly discharged pediatric home mechanical ventilation patients. Pediatr Pulmonol. 2012;47(4):409‐414. doi:10.1002/ppul.21536
-
- Russell CJ, Mamey MR, Koh JY, Schrager SM, Neely MN, Wu S. Length of stay and hospital revisit after bacterial tracheostomy‐associated respiratory tract infection hospitalizations. Hospital Pediatrics. 2018;8(2):72‐80. doi:10.1542/hpeds.2017-0106
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
